MG

Oncology

26 drugs in development·19 companies·2 clinical trials

Drug Pipeline by Phase

Approved(15)

Drug	Company
ARISTADA INITIO	Alkermes plc. (ALKS)
bicalutamide	SUNSET ISLAND GROUP (SUN)
bicalutamide	Aptinyx Inc. (APTX)
deferasirox	Amneal Pharmaceuticals, Inc. (AMRX)
fenofibrate	Amneal Pharmaceuticals, Inc. (AMRX)
fluorescein	NEXUS BIOPHARMA INC (NEXS)
guselkumab	Vor Biopharma Inc. (VOR)
oxycodone	NULIFE SCIENCES, INC. (NULF)
pitavastatin	Mylan II B.V. (MYL)
rystiggo	KORU Medical Systems Inc. Common Stock (DE) (KRMD)
Ultomiris	Xencor Inc (XNCR)
vascepa	AMARIN CORP PLCUK (AMRN)
VASCEPA (VAZKEPA in EU)	AMARIN CORP PLCUK (AMRN)
VASCEPA (VAZKEPA)	AMARIN CORP PLCUK (AMRN)
yorvipath	Ascendis Pharma A/S (ASND)

Phase 3(3)

Phase 2(2)

Drug	Company
m281	MOMENTA PHARMACEUTICALS INC (MNTA)
rese-cel	Cabaletta Bio, Inc. (CABA)

Phase 1(5)

Drug	Company
CABA-201	Filana Therapeutics Inc. (FLNA)
rese-cel (resecabtagene autoleucel)	Cabaletta Bio, Inc. (CABA)
Selinexor	Merus N.V. (MRUS)
Selinexor	PTC THERAPEUTICS, INC. (PTCT)
Selinexor	Black Diamond Therapeutics, Inc. (BDTX)

Unknown(1)

Drug	Company
Effin'	Ascend Wellness Holdings, Inc. (AAWH)

BioSniper tracks 26 drugs in development for MG across 19 companies.

There are 2 clinical trials targeting MG tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.